Validating novel biomarkers relevant to major depression

验证与重度抑郁症相关的新型生物标志物

• 批准号: nhmrc : 1145770
• 负责人: Prof Julio Licinio
• 金额: $ 34.86万
• 依托单位: Flinders University
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2018
• 资助国家: 澳大利亚
• 起止时间: 2018-01-01 至 2020-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/validating-novel-biomarkers-major-depression/1320520
• 关键词: Validating; novel; biomarkers; relevant; major

Depression prevention and treatment are public health priorities; therefore, it is critical to improve and personalise treatments, which can only be achieved by advancing knowledge of its underlying biology. This research project will contribute to validating potentially relevant genes for MDD risk or antidepressant response and to provide the scientific foundation for future strategies to test their products as MDD biomarkers in the clinical setting.

抑郁症的预防和治疗是公共卫生的优先事项;因此，改善和个性化治疗至关重要，这只能通过提高其潜在生物学知识来实现。该研究项目将有助于验证MDD风险或抗抑郁反应的潜在相关基因，并为未来在临床环境中测试其产品作为MDD生物标志物的策略提供科学基础。